CAM
MLAB icon

Cresset Asset Management’s Mesa Laboratories MLAB Stock Holding History

Cresset Asset Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,701
Closed -$221K – 2031
2024
Q3 		$221K Buy
+1,701
New +$200K ﹤0.01% 1945
2021
Q4 		– Sell
-731
Closed -$221K – 1226
2021
Q3 		$221K Buy
+731
New +$208K ﹤0.01% 992
2021
Q2 		– Sell
-851
Closed -$207K – 1057
2021
Q1 		$207K Buy
851
+101
+13% +$27.8K ﹤0.01% 850
2020
Q4 		$215K Buy
+750
New +$206K ﹤0.01% 688
2019
Q2 		– Sell
-16
Closed -$4K – 1189
2019
Q1 		$4K Buy
+16
New +$3.62K ﹤0.01% 1428

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cresset Asset Management's MLAB Position: Q4 2024 in Review

Cresset Asset Management sold out of Mesa Laboratories (MLAB) in Q4 2024, closing a stake of 1,701 shares — an estimated $221K sold.

Cresset Asset Management first reported a position in MLAB in Q1 2019 and held it in 5 quarters. The position peaked at $221K in Q3 2021. 156 funds tracked by Wall St. Rank hold MLAB as of Q4 2024.

  • Cresset Asset Management reported no remaining Mesa Laboratories position as of Q4 2024 after selling out during the quarter.
  • Cresset Asset Management sold 1,701 Mesa Laboratories shares in Q4 2024, an estimated $221K.
  • Cresset Asset Management first reported a position in Mesa Laboratories in Q1 2019 and held it in 5 quarters.
  • Cresset Asset Management's Mesa Laboratories position peaked at $221K in Q3 2021.
  • 156 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2024.

Based on Cresset Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.